PHENOTYPIQ Trademark

Trademark Overview

On Friday, April 7, 2023, a trademark application was filed for PHENOTYPIQ with the United States Patent and Trademark Office. The USPTO has given the PHENOTYPIQ trademark a serial number of 97878765. The federal status of this trademark filing is REGISTERED as of Tuesday, March 25, 2025. This trademark is owned by Quantiscope, Inc.. The PHENOTYPIQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Software design and development; Image processing software design
phenotypiq

General Information

Serial Number97878765
Word MarkPHENOTYPIQ
Filing DateFriday, April 7, 2023
Status700 - REGISTERED
Status DateTuesday, March 25, 2025
Registration Number7740014
Registration DateTuesday, March 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Pseudo MarkPHENOTYPE IQ
Goods and ServicesDrug discovery services; Software design and development; Image processing software design

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 2, 2023
Primary Code042
First Use Anywhere DateMonday, January 1, 2024
First Use In Commerce DateMonday, January 1, 2024

Trademark Owner History

Party NameQuantiscope, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101
Party NameQuantiscope, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101
Party NameQuantiscope, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84101

Trademark Events

Event DateEvent Description
Monday, December 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 11, 2023NEW APPLICATION ENTERED
Tuesday, May 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024ASSIGNED TO EXAMINER
Wednesday, January 3, 2024NON-FINAL ACTION WRITTEN
Wednesday, January 3, 2024NON-FINAL ACTION E-MAILED
Wednesday, January 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 18, 2024USE AMENDMENT FILED
Wednesday, December 18, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, March 1, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 5, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 5, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 5, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

phenotypiq design software image processing development discovery drug services